Last updated on November 2006

Efficacy of Retreatments With Intravitreal Bevacizumab


Brief description of study

Choroidal neovascularization is a leading cause of visual loss in people older than 60 years and for its treatment there had been performed multicentric studies with Lucentis (Ranibizumab) with a significant improval of visual acuity. In our institution we evaluated efficacy of bevacizumab in several pathologies but we dont know what would be the results if we use the same dose several times. Our purpose was to determine the efficacy of bevacizumab for improve or stabilize visual acuity with two or more intravitreal inyections of bevacizumab.

Clinical Study Identifier: NCT00406744

Contact Investigators or Research Sites near you

Start Over

Veronica Kon-Jara, MD

Asociacion para Evitar la Ceguera en Mexico
Mexico DF, Mexico
  Connect »